Discover investment opportunities in Stocks Under $2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Under $2 using our Smart AI Filter.
8 stocks found for "Stocks Under $2"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.52 | ±84.5% | -2.2 | 0.00% | |||
0.88 | ±63.0% | -95.7 | 0.00% | |||
1.46 | ±85.2% | -0.9 | 0.00% | |||
0.55 | ±66.4% | -1.5 | 0.00% | |||
0.79 | ±46.9% | -62.2 | 0.00% | |||
1.63 | ±100.0% | -2.5 | 0.00% | |||
2.07 | ±100.0% | -4.2 | 0.00% | |||
1.19 | ±88.4% | -5.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What factors should investors consider when evaluating SENS stock, particularly as it's a low-priced stock?
A: SENS, being a low-priced stock, may attract investors interested in high-risk, high-reward opportunities. Important factors include its financial health, product pipeline in the medical technology sector, and any strategic partnerships. Such stocks can exhibit high volatility and may be influenced by company-specific news and FDA approvals.
Q: How does ATOS's position in pharmaceuticals impact its investment potential under $2?
A: ATOS operates in the pharmaceutical sector, where its investment potential may hinge on drug development milestones and regulatory approvals. Low-priced stocks like ATOS can be attractive for speculative investors looking for biotech breakthroughs but pose risks if clinical trials underperform.
Q: Why might investors be interested in ZOM, a stock under $2 focusing on veterinary health?
A: ZOM, targeting the growing veterinary health market, presents opportunities due to increased pet ownership and healthcare spending. Investors may consider its product commercialization success in the sector, but should be aware of the inherent risks in low-cap stocks.
Q: What should investors know about QNCX's recent performance trends?
A: For QNCX, investors should examine its latest earnings reports, product pipeline in the biopharmaceutical sector, and any strategic collaborations. As a stock under $2, its appeal might be centered on emerging markets yet carries significant volatility.
Q: How might IMUX's focus on immunotherapy influence its stock volatility?
A: IMUX is engaged in developing immunotherapies, a high-stakes area within biotechnology. Regulatory approvals or setbacks can lead to high volatility, common among stocks below $2. Investors may weigh this against potential breakthroughs in treatment.
Q: What are the investment risks associated with URG, a uranium-focused stock?
A: URG's involvement in uranium production exposes it to commodity price fluctuations and regulatory shifts in energy policies. As a low-cost stock, macroeconomic factors and energy demand directly impact its investment risk profile.